2 results
Approved WMOCompleted
to assess patient's overall preference for the two inhaler devices in COPD patients after 2 weeks of dialy practice.
Approved WMOWill not start
To evaluate whether the efficacy in terms of progression free survival (PFS) of second-line tepotinib in combination with gefitinib is superior to pemetrexed+cisplatin/carboplatin in subjects with T790M negative, MET+ locally advanced or metastatic…